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Abstract
Introduction: Concerns over dimethyl sulfoxide (DMSO) toxicity, related to adverse reactions after hematopoietic stem 
cells (HSCs) therapy, warrant the development of an optimized DMSO-free or DMSO-reduced cryopreservation protocol 
for the quality and safety of HSCs.
In this regard, the ideal concentration of trehalose, as a non-toxic natural cryoprotectant, is still an area of research. 
Based on the outcome of our previous study on lower concentrations of trehalose, the present study was focused on 
evaluating its cryoprotective efficacy at an increased concentration (0.5 M) on HSCs compared to 10% DMSO. This is 
a laboratory-based experimental study.
Material and methods: The separated mononuclear cells collected from umbilical cord blood were set for culture up to 
two passages to get HSCs. The two different concentrations of trehalose, with and without 5% DMSO, were considered 
as freezing media for the preservation of the harvested HSCs in a slow freezing set up. Two sequential functional assays, 
viability followed by hematopoietic colony-forming unit assay, were performed with post-thawed cells of freezing media 
used in this study. Seventeen cord blood samples were selected.
Results: Study results revealed 0.5 M trehalose and DMSO 5% showed the highest viability of 91.8 ±2.8% of HSCs. 5% 
DMSO inclusion to trehalose (0.5 M) ameliorated hematopoietic colonies such as erythroid and myeloid colonies with 
no significant difference from that of 10% DMSO.
Conclusion: 0.5 M trehalose has proved to be a better concentration than 10% DMSO alone. This experimental study 
needs further transplantation-based clinical trials using post-thawed cells to ensure the safety of preserved HSCs from 
cord blood and other sources.
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Introduction
The clinical utility of cryopreserved hematopoietic stem cells 
(HSCs) faces challenges related to the quality and safety of 
cellular products. The effective therapeutic use of cryopre-
served HSCs depends on the ideal cryoprotective behavior 
of cryoprotective agents (CPAs) or cryoprotectants [1]. Mo-
reover, several adverse reactions after transplantation have 
been associated with standard dimethyl sulfoxide (DMSO) 
(10%) inclusion as CPA for cryopreservation of stem cells 
[2, 3]. As DMSO toxicity to cells is concentration-dependent, 
even its absence in the freezing medium, or total removal 
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before transfusion, would not be better in terms of the 
need to reduce toxicity [4, 5]. The preclinical evaluation of 
an automated sequential washing procedure for pot-thaw 
DMSO exclusion in HPC grafts has proven to be effective [6].
DMSO removal from long-term frozen PBSC grafts using 
a fully automated, closed system washing device has been 
shown to result in a high recovery of viable CD34+ cells [7]. 
Additionally, reduced concentration of DMSO (5%) alone has 
been recommended to enhance the kinetics of engraftment 
[8], which can be further lessened by adopting a combination 
of DMSO with another cryoprotectant solution [9]. Complex 
carbohydrates such as hydroxy ethyl starch (HES) and dextran, 
the synthetic polymer of glucose, are used as cryoprotectants 
along with DMSO at their different concentrations for various 
cell types. Many studies have adopted a standardized combi-
nation of 5% DMSO with 6% HES and 10% DMSO with a 2% 
dextran freezing medium. But improved post-thaw viability 
and hematopoietic functionality of CB stem cells have been 
demonstrated by a freezing medium containing 5% DMSO 
and 5% pentastarch HES [10], rather than 10% DMSO [11].
Furthermore, the safety of using HES alone as a cry-
oprotectant or in combination with other CPAs has been 
reviewed [12], though HES is less toxic than DMSO. Even 
these synthetic colloids are known to be associated with 
adverse drug reactions when used for several therapeutic 
purposes [13, 14], warranting the safety of cellular pro-
ducts used for transfusion.
In this regard, natural, non-toxic sugars such as trehalo-
se and sucrose come under the spotlight because they are 
used by organisms to combat overstress conditions such as 
heat, cold, and desiccation sugars [15]. These disaccharides 
are used as CPA with and without DMSO [16]. In our earlier 
study, the cryoprotective effect of these two sugars at only 
low concentrations was very poor, and improved with 2% 
DMSO inclusion for cord blood-derived mononuclear cells 
(MNCs) [17]. But 10% of DMSO was not taken as a variable.
Hence the above findings pave the way for the as-
sessment of the cryoprotective behavior of trehalose at 
its higher concentration (0.5 M) with or without the inclu-
sion of 5% DMSO rather than 10% DMSO, using a conven-
tional slow cooling method for cultured HSCs, because 
chemical toxicity and extreme osmotic stress conditions 
are associated with vitrification. Colony forming unit (CFU) 
has been recommended as being an excellent measure 
of viable stem cells and cell division and colony formation 
over time [18], something which aligns with the preclinical 
quality assessment of post-thawed products in our study.
Materials and methods
Experimental design
This present study was designed to assess the cryoprotec-
tive effectiveness of trehalose on harvested HSCs (derived 
from UCB), compared to standard 10% DMSO.
Our study objective was accomplished in four sequen-
tial phases:
 ■ in vitro culture of MNCs (isolated from CB) for the yield 
of HSCs;
 ■ cryopreservation of HSCs with six different freezing 
media i.e. media containing trehalose (0.2 M, 0.5 M) 
alone, 5% DMSO in combination with trehalose (0.2 M, 
0.5 M), 5% DMSO, and conventional 10% DMSO alone;
 ■ post thawed viability analysis of cryopreserved HSCs of 
the six participating freezing media by taking five diffe-
rent measurements (replicates) for each one;
 ■ hematopoietic functionality assay of the post thawed 
HSCs of freezing media (showing superior post-thawed 
HSCs viability) by considering three different measure-
ments for each one.
The current study is an unpublished part of project 
work funded by the Department of Science & Technology 
(DST), Government of India. It was approved by Institutional 
Ethical Committee (IEC), S.C.B. Medical College, Cuttack, 
approval no. IEC.157/30.08.2012. CB collection was per-
formed (irrespective of the gender of the newborn) from 
the Department of Obstetrics and Gynecology with infor-
med consent from mothers. While it was processing, an 
in vitro culture of HSCs and cryopreservation studies were 
accomplished in the Department of Biochemistry, S.C.B. 
Medical College, Cuttack. Samples of cords of full-term 
deliveries from cesarean sections were preferred as sam-
ple collection from vaginal deliveries in the labour room 
was mostly associated with microbial contamination due 
to imperfect hygiene.
Inclusion criteria
The selection of full-term CB samples was based on the 
absence of indications such as septicemia, other hema-
tological infections or complications, and viral infections 
(VDRL, human immunodeficiency, hepatitis B, hepatitis C). 
Other criteria such as samples having any congenital or 
chromosomal anomalies, inaccurate/unknown gestational 
age, and signs of hemolysis, were also excluded.
Isolation of MNCs from CB
Cord blood (65–70 mL) was collected using citrate–phos-
phate–dextrose (CPD, Sigma-Aldrich, USA) as an anticoagu-
lant during collection and diluted with phosphate buffered 
saline A (PBS without Ca2+/Mg2+, HIMEDIA, India) in a 1:1 
ratio. MNCs from CB were recovered from the interface 
obtained by density gradient centrifugation (1.077 g/mL 
Histopaque, Sigma). The collected MNCs were washed 
twice with PBS to remove any residual RBCs. The CB pro-
cessing time was within seven hours of collection without 
hemolysis or coagulation. In the present study, we avoided 
the RBC lysis method which may have some impact on 
the cell microenvironment during the separation process, 
affecting cell viability [19].
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Non-adherent HSCs harvest
For the primary culture of MNCs, we used a culture medium 
containing Dulbecco’s Modified Eagle’s Medium (DMEM, 
PAN-BIOTECH, Germany), 10% fetal bovine serum (FBS, 
PANBIOTECH, Germany), and 1% penicillin, streptomycin 
antibiotics (Himedia, India). Cell cultures were carried out 
at 37°C in a humidified atmosphere of 95% air and 5% 
CO2 after plating the cells at a density of 1 ×106/cm2 in 
the culture medium. The medium was replaced by a fresh 
one after 48 h. The floating non-adherent cells of culture 
were removed from the adherent layer and cultured sepa-
rately. Culture media having Iscove’s Modified Dulbecco’s 
Medium with L-glutamine (IMDM, PAN-BIOTECH, Germany) 
containing 10% FBS, 1% penicillin, streptomycin antibio-
tics was used for non-adherent cells culture at a seeding 
density of 1 ×104/cm2. The culture was fed on alternate 
days. Media with cultured cells were centrifuged at 1,500 
rpm for 5 min after the 7th day of culture. The cells were 
then washed with PBS-A and counted in a hemocytometer.
Preparation of freezing media
Based on our current study design, two different concentra-
tions of trehalose, i.e. 0.2 M and 0.5 M, were considered 
for the preparation of four different types of cryoprotective 
media (as presented in Table I) for evaluation of their opti-
mal cryoprotective function. These media were mostly com-
posed of 10% bovine serum albumin (BSA, PANBIOTECH, 
Germany) in Dulbecco’s Modified Eagle’s Medium (DMEM, 
PAN-BIOTECH, Germany) to which trehalose (Himedia, India) 
was added alone or with 5% DMSO. All freezing media were 
freshly prepared and cooled at 4ºC. The control media were 
5% and 10% DMSO only.
Freezing and thawing of HSCs
After the preparation of the abovementioned freezing 
media, 2 ×106 HSCs were suspended with 1.8 mL of the 
freezing medium of each group separately in a 2 mL of 
cryovial tube and immediately transferred to an isopro-
panol container (Tarson) for freezing at –80°C overnight 
with a cooling rate of 1°C/min. Finally, the isopropanol 
container was transferred to the canister and stored in the 
vapor phase of liquid nitrogen (at –156°C) for one month 
until further analysis.
To thaw the cryopreserved samples, DMEM media with 
heat-inactivated 10% fetal bovine serum (FBS) was used. 
The cryovials, removed from the liquid nitrogen tank, were 
immediately placed in a water bath maintained at 37°C 
until ice crystals started to disappear and transferred to 
a 50 ml centrifuge tube, with the thawing medium added 
slowly in the ratio of 2:1 to the cell suspension. The HSCs 
were recovered by centrifugation at 1,500 rpm for 6 min 
at room temperature. Excess supernatant was decanted 
and the cell pellet was suspended in the above prewarmed 
(warmed for 5–6 min at a temperature of 37°C) thawing 
medium. Further washing of recovered HSCs was done twi-
ce with thawing media by centrifugation. Cryopreservation 
and post-thaw viability assay of preserved HSCs were per-
formed in five replicates.
Cell viability was calculated using the following formula:
% viability = the number of viable post-thawed HSCs 
×100/total number of HSCs before freezing
Colony forming unit (CFU) assay
Hematopoietic colony-forming unit assay
For the assessment of the functional activity of post thawed 
HSCs, a colony-forming unit assay was performed. Cell 
dose of approximately 2 ×105 cells was set for culture by 
incubating the cells in methylcellulose medium, provided 
in the kit (Stem Cell Technologies, Vancouver, BC, Canada) 
containing hematopoietic growth factors, for two weeks 
according to the standard procedures [20]. Scoring of 
generated hematopoietic colonies was based on their re-
lative distribution in each culture plate after two weeks (as 
stated in the information sheet of the kit). Hematopoietic 
colonies such as erythroid lineage-based burst forming 
unit-erythroid/colony forming unit-erythroid (BFU-E/CFU-E), 
myeloid lineage-based colony forming unit-granulocyte, 
macrophage (CFU-GM), and the mixed type colony-forming 
unit-granulocyte, erythroid, macrophage, megakaryocyte 
(CFU-GEMM), were scored under an inverted microscope.
Statistical analysis
Statistical data was presented as mean ±standard de-
viation (SD) and analyzed by ANOVA and Student’s t-test 
with significant p value <0.05, using GraphPad PRISM 5 
software.
Results
Twenty cord blood samples were selected according to the 
study inclusion criteria. During transportation from the De-
partment of Obstetrics and Gynecology to the laboratory for 
sample processing, hemolysis occurred in three samples. 
The mean volume of total studied samples was 65.31 
±4.55 mL, and the mean number of MNCs obtained after 
density gradient centrifugation was 0.602 ±0.06 ×109.
Following cryopreservation, optimum scoring of the 
freezing media was based on post-thaw cell viability assay. 
Table I. Preparation of two different groups of disaccharide-ba-
sed freezing media in combination, with and without 5% dimethyl 
sulfoxide (DMSO) for cryopreservation
Group I freezing media Group II freezing media
Disaccharides alone Disaccharide media  
with introduction of 5% DMSO
0.2 M trehalose 0.2 M trehalose with 5% DMSO
0.5 M trehalose 0.5 M trehalose with 5% DMSO
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A clonogenic CFU assay for each optimized medium was 
performed in triplicates only (a total of 12 CFU assays).
Post-thaw viability of HSCs
The highest viability percentage, of 91.8 ±2.86%, was 
demonstrated by the freezing medium containing 0.5 M 
trehalose and DMSO (5%) with no significant difference 
from that of 10% DMSO (p =0.4433), as set out in Figure 1. 
Trehalose alone revealed better post-thaw cell viability at 
its higher concentration (0.5 M) than the lower one (0.2 M) 
with p <0.05. A similar outcome was observed even after 
the addition of DMSO to both of its concentrations. Moreo-
ver, post-thaw viability was significantly higher in the case 
of 0.5 M trehalose with 5% DMSO medium compared to 
5% DMSO alone (p <0.0001).
Hematopoietic functional outcome
Optimal post-thaw viability displayed by the trehalose 
(0.5 M) based freezing medium with and without 5% DMSO 
weas selected for CFU Assay. After 14 days of incubation 
with methylcellulose medium, three types of colonies, BFU-E/ 
/CFU-E, CFU-GM, and CFU-GEMM, were developed in each 
culture plate. The total number of hematopoietic colonies 
(i.e. adding up the BFU/CFU, CFU-GM and CFU-GEMM 
colonies) produced by post-thawed HSCs of each freezing 
medium, are set out as mean (SD) in Table II. Here, for each 
medium, three different measurements were considered 
for the total number of hematopoietic colonies.
The presence of DMSO in 0.5 M trehalose media ame-
liorated the total number of hematopoietic colonies (mean 
±SD) rather than its complete absence (Table II). A similar 
effect was pronounced during individual hematopoietic co-
lony scoring (Figure 2). 0.5 M trehalose exhibited more my-
eloid lineage-based (CFU-GM) and less mixed (CFU-GEMM) 
colonies than 5% DMSO, with p =0.008 and p =0.001 re-
spectively. But there was a significant difference in the yield 
of both myeloid (p <0.0001) and erythroid (p =0.0002) 
colonies in trehalose media only after the inclusion of 5% 
DMSO compared to 5% DMSO alone.
The functional activity of post-thawed HSCs preserved 
in a conventional freezing medium of 10% DMSO was com-
pared to that of 0.5 M trehalose in combination with 5% 
DMSO. No significant differences were found in the num-
ber of erythroid (p =0.0832), myeloid (p =0.1121), or mi-
xed type (p =0.3611) colonies.
Discussion
To address the contradictory consequence of both cryopro-
tection and toxicity resulting from routine use of a standard 
DMSO dose (10%), additional CPAs like natural disaccha-
rides remain the focus of discussion. The dipole potential 
of the cell membrane is decreased with an increasing con-
centration of trehalose owing to its bioprotective function 
Table II. Total number of hematopoietic colonies as generated  
by different cryoprotective media used
Type of cryoprotective medium Total number of colonies 
(mean ±SD)
10% DMSO 256 ±5.51
5% DMSO 138 ±4.51
0.5 M trehalose 154 ±4.73
0.5 M trehalose +5% DMSO 276 ±9.07
All data represented as mean ±standard deviation (SD) for triplicates; DMSO — dimethyl 
sulfoxide
Figure 1. Viability percentages as shown by different media. All 
data represented as mean ±standard deviation for five replicates; 
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Figure 2. Comparison of three types of hematopoietic colonies 
distribution during colony forming unit (CFU) assay. All data 
represented as mean ±standard deviation (SD) of three dif-
ferent measurements for each freezing medium; BFU-E/CFU-E 
— burst forming unit-erythroid/colony forming unit-erythroid; 
DMSO — dimethyl sulfoxide; CFU-GM — myeloid lineage-based 
colony forming unit-granulocyte, macrophage; CFU-GEMM — 
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[21], which was observed by increasing the concentration 
of trehalose from 0.2 M to 0.5 M in our study. Furthermore, 
the conventional method of DMSO removal comprises the 
repeated process of immediate centrifugation of thawed 
cell products, the removal of the supernatant, and the ad-
dition of fresh solution to the cell population. We adopted 
this traditional procedure for washing thawed products 
instead of new technology-based washing devices, which 
already exhibit high recovery of viable CD34+ cells, with 
good engraftment potential in some of the studies [22, 
23]. volume reduction in DMSO concentration still does 
not have any impact on engraftment after autologous pe-
ripheral blood stem cell (PBSC) transplantation as reported 
by one of the clinical studies [24].
The impact of trehalose at its 0.5 M concentration 
alone contributes similar results to those of 10% DMSO 
in the preservation of stem cells derived from BM and 
PB [25]. The reported results are not in agreement with 
the current data. Conversely, post-thawed assessment 
outcomes of existing data exhibit efficient cryoprotection 
only by combined media of trehalose and DMSO on cord 
blood HSCs. One of the recent relevant studies on PBSCs 
demonstrates improved cryoprotection by 1 M trehalose 
alone to CD34+ cells compared to the standard freezing 
procedure that uses 10% DMSO [16], where the cut off 
value of trehalose concentration is 1 M without the use 
of DMSO and catalase.
The quality of post-thawed HSCs involves phenotypical 
characterization of cells by flow-cytometric analysis to de-
termine cell viability (viability dye 7-AAD) and cell type (CD 
34 count) and furthermore by CFU analysis.
But post-thaw viability of cells does not guarantee post-
-thaw cell functionality.
Delayed engraftments have been observed regardless 
of adequate post-thaw viability of CD34+ cells [26]. Post-
-thaw cell functionality can be assessed by the CFU test, 
as this is a decisive step before heading for clinical trials 
[27]. This is a powerful measure of engraftment related to 
UCB transplantation [18].
The results of the functional assay (CFU) of post thawed 
cells in the current study confirm that 0.5 M trehalose in 
association with 5% DMSO can be an ideal cryoprotective 
solution, and could act as a valuable alternative to the ty-
pical 10% DMSO medium.
This simple cryopreservation method needs further cli-
nical trials based on investigations to ascertain the safety 
of using preserved HSCs for myriad diseases in a tertiary 
care center setting, because it is a cost-effective cryopre-
servation protocol.
Limitations
Time programmed freezing methods and new technology-
-based well-established washing devices were not used for 
this study due to inadequate allocated funds.
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